Sunday, June 1, 2025

Latest

Cannabis Equities Hit Hard Following Ballot Failure In Florida

Cannabis stocks are having a major red day on the markets, following the results of yesterdays election in the United States. The strong decline is believed to be related to a mix of recreational amendments failing along with the failure of the Democrats, who are traditionally more open to legalization, to secure any major wins in the race.

Most impacted by the results is Trulieve Cannabis (CSE: TRUL), who is the largest loser on the Canadian markets today. The company, who spent nearly $145 million on attempting to get Amendment 3 passed in Florida, has declined by 37% on the day, following the amendments failure to secure the required 60% approval to pass.

The amendment, while supported by a majority of voters at 55.9%, failed to hit the required threshold for passing. Had it passed, it would have enabled recreational legalization to occur in the state of Florida.

This failure in Florida is believed to be the driving force behind the decline in the AdvisorShares Pure Cannabis ETF (NYSE: MSOS), which is currently down 27% on the day.

Viewed as a bellwether for the entire cannabis sector, the decline in the ETF is blamed for the massive declines seen across the board.

The performance of other equities involved in the cannabis space include:

  • The Cannabist Company (NEO: CBST): -25%
  • Curaleaf Holdings (TSX: CURA): -24.6%
  • TerrAscend Corp (TSX: TSND): -20.7%
  • Ascend Wellness (CSE: AAWH-U): -20.2%
  • Cresco Labs (CSE: CL): -19.6%
  • Verano Holdings (NEO: VRNO): -19.5%
  • Planet 13 Holdings (CSE: PLTH): -19.0%
  • Green Thumb Industries (CSE: GTII): -18.4%

The losses also extend to Canadian cannabis operators, with Canopy Growth (TSX: WEED) presently down 21.5%, and Aurora Cannabis (TSX: ACB), whom reported earnings this morning, down 18.1%. The trouble for cannabis equities moving forward, is the lack of a positive catalyst on the horizon, with the potential rescheduling of cannabis to a Schedule 3 drug having no definitive date at this time.


Information for this briefing was found via Sedar and the companies mentioned. The author has no securities or affiliations related to this organization. Not a recommendation to buy or sell. Always do additional research and consult a professional before purchasing a security. The author holds no licenses.

Leave a Reply

Video Articles

Alamos Gold Q1 Earnings: The Inside Scoop

Cerrado Gold Q4 Earnings: The Turnaround is Working

B2GOLD Q1 Earnings: Revenue Up, Production & Cash Flow Decline

Recommended

Canadian Copper: The $172M Combined Strategy PEA

ESGold Begins Concentration Tests Ahead Of First Production

Related News

Trulieve’s Q3 2024 Loss Jumps 137% Amid Push for Florida Legalization

Trulieve Cannabis Corp. (CSE: TRUL) released its third-quarter earnings report today, presenting financial data that...

Tuesday, November 5, 2024, 03:04:00 PM

DeSantis Thinks Marijuana Amendment Will Make Florida ‘More Blue’

Florida Governor Ron DeSantis has intensified his opposition to Amendment 3, a ballot initiative aimed...

Friday, July 19, 2024, 08:11:20 AM

Harvest Health: The Bridging Harvest

The Deep Dive has identified Harvest Health as one of three Canadian cannabis companies that...

Tuesday, April 5, 2022, 03:30:00 PM

Trulieve’s Net Losses In Q3 2022 Widened By Five Times

The cannabis firm sees revenue down sequentially while inventories are on an upward trend. Trulieve...

Thursday, November 10, 2022, 03:14:00 PM

Following ‘Catastrophic Hurricane Season,’ Insurers Continue to Exit Florida

AAA has announced that it will not be renewing auto and home insurance policies for...

Monday, July 17, 2023, 01:38:00 PM